Edgewise Therapeutics, Inc. EWTX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $42.65M-2.2% | $43.59M+16.3% | $37.48M+11.7% | $33.56M-8.7% | $36.76M+1.1% | ||
| $11.46M-7.4% | $12.39M+32.1% | $9.38M+3.6% | $9.05M-1.6% | $9.2M+0.3% | ||
| $54.12M-3.3% | $55.98M+19.5% | $46.86M+10.0% | $42.61M-7.3% | $45.96M+0.9% | ||
| -$54.12M+3.3% | -$55.98M-19.5% | -$46.86M-10.0% | -$42.61M+7.3% | -$45.96M-0.9% | ||
| -$49.01M+2.4% | -$50.22M-23.5% | -$40.67M-12.6% | -$36.12M+11.5% | -$40.8M-2.9% | ||
| -$0.46+4.2% | -$0.48-23.1% | -$0.39-14.7% | -$0.34+20.9% | -$0.43-2.4% | ||
| -$53.58M+3.4% | -$55.45M-19.6% | -$46.36M-10.1% | -$42.11M+7.3% | -$45.45M-1.1% | ||
| -$54.12M+3.3% | -$55.98M-19.5% | -$46.86M-10.0% | -$42.61M+7.3% | -$45.96M-0.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Edgewise Therapeutics, Inc.'s income statement data come from?
- Every line is extracted from Edgewise Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.